Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease

Journal of Clinical Microbiology

Volumn 52, Issue 12, 2014, Pages 4217-4223

  Garcia Nuñez, Marian ^a,b,c,d   Millares, Laura ^a,b,c,d   Pomares, Xavier ^c,h   Ferrari, Rafaela ^e,f,g   Pérez Brocal, Vicente ^e,f,g   Gallego, Miguel ^c,h   Espasa, Mateu ^h   Moya, Andrés ^e,f,g   Monsó, Eduard ^a,b,c,h  

^a Fundació Parc Taulí   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Servei d'Hematologia   (Spain)

^e Generalitat Valenciana   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h Servei de Pneumologia Hospital Universitari Parc Taulí   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; BACTERIAL DNA; RIBOSOME DNA;

ACTINOBACTERIA; ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRMICUTES; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUSOBACTERIUM; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; LUNG FUNCTION; MALE; MICROBIAL DIVERSITY; MOLLICUTES; MORAXELLA CATARRHALIS; NONHUMAN; PROTEOBACTERIA; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; RNA GENE; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SYNERGISTETES; ANIMAL; BACTERIUM; CHEMISTRY; CLASSIFICATION; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDY; DNA SEQUENCE; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PHYLOGENY; SPUTUM;

AGED; ANIMALS; BACTERIA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 84910115459     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01967-14     Document Type: Article

References (31)

1. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ. 2012. Significance of the microbiome in obstructive lung disease. Thorax 67:456-463. http://dx.doi.org/10.1136/thoraxjnl-2011-201183.
2. Marin A, Monso E, Garcia-Nunez M, Sauleda J, Noguera A, Pons J, Agusti A, Morera J. 2010. Variability and effects of bronchial colonisation in patients with moderate COPD. Eur. Respir. J. 35:295-302. http://dx.doi.org/10.1183/09031936.00126808.
3. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. 2000. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am. J. Med. 109:288-295. http://dx.doi.org/10.1016/S0002-9343(00)00507-6.
4. Sethi S, Evans N, Grant BJ, Murphy TF. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471. http://dx.doi.org/10.1056/NEJMoa012561.
5. Hayashi H, Sakamoto M, Benno Y. 2002. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol. Immunol. 46:535-548. http://dx.doi.org/10.1111/j.1348-0421.2002.tb02731.x.
6. Morgan XC, Huttenhower C. 2012. Chapter 12: human microbiome analysis. PLoS Comput. Biol. 8:e1002808. http://dx.doi.org/10.1371/journal.pcbi.1002808.
7. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J. 1999. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl. Environ. Microbiol. 65:4799-4807.
8. Cabrera-Rubio R, Garcia-Nunez M, Seto L, Anto JM, Moya A, Monso E, Mira A. 2012. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J. Clin. Microbiol. 50:3562-3568. http://dx.doi.org/10.1128/JCM.00767-12.
9. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. 2011. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 6:e16384. http://dx.doi.org/10.1371/journal.pone.0016384.
10. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO. 2010. Disordered microbial communities in asthmatic airways. PLoS One 5:e8578. http://dx.doi.org/10.1371/journal.pone.0008578.
11. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2014. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org/uploads/users/files/GOLD-Report-2014-Jun11.pdf.
12. ATS. 1995. Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med. 152:1107-1136. http://dx.doi.org/10.1164/ajrccm.152.3.7663792.
13. ATS. 2002. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 166:111-117. http://dx.doi.org/10.1164/ajrccm.166.1.at1102.
14. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 350:1005-1012. http://dx.doi.org/10.1056/NEJMoa021322.
15. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R, Casan P, Sans S. 1986. Spirometric reference values from a Mediterranean population. Bull. Eur. Physiopathol. Respir. 22:217-224.
16. Murray PR, Washington JA. 1975. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin. Proc. 50:339-344.
17. Van Scoy RE. 1977. Bacterial sputum cultures: a clinician's viewpoint. Mayo Clin. Proc. 52:39-41.
18. Efthimiadis A, Jayaram L, Weston S, Carruthers S, Hargreave FE. 2002. Induced sputum: time from expectoration to processing. Eur. Respir. J. 19:706-708. http://dx.doi.org/10.1183/09031936.02.00104002.
19. Balows A. 1991. Manual of clinical microbiology. American Society for Microbiology, Washington, DC.
20. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Lozupone CA, Hamady M, Knight R, Bushman FD. 2008. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 4:e20. http://dx.doi.org/10.1371/journal.ppat.0040020.
21. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75:7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
22. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7:335-336. http://dx.doi.org/10.1038/nmeth.f.303.
23. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL. 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72:5069-5072. http://dx.doi.org/10.1128/AEM.03006-05.
24. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. 2011. Metagenomic biomarker discovery and explanation. Genome Biol. 12:R60. http://dx.doi.org/10.1186/gb-2011-12-6-r60.
25. Chao A. 1984. Nonparametric estimation of the number of classes in a population. Scand. J. Stat. 11:265-270.
26. Shannon CE. 1997. The mathematical theory of communication: 1963. MD Comput. 14:306-317.
27. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. 2011. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184:957-963. http://dx.doi.org/10.1164/rccm.201104-0655OC.
28. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305. http://dx.doi.org/10.1371/journal.pone.0047305.
29. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. 2010. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5:e11044. http://dx.doi.org/10.1371/journal.pone.0011044.
30. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, Wolfgang MC. 2012. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One 7:e45001. http://dx.doi.org/10.1371/journal.pone.0045001.
31. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. 2012. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. U. S. A. 109:5809-5814. http://dx.doi.org/10.1073/pnas.1120577109.